Mikiu Diabolo

Anter

• E kūpono paha no ...
• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

ʻO ka māiʻuʻu ʻo Diabolo kahi mea kanu. ʻO ka inoa botanical, Harpagophytum, ʻo ia hoʻi "mea kanu lou" i ka Helene. Loaʻa ka inoa o kēia mea kanu mai ke ʻano o kāna hua, i uhi ʻia me nā makau i pili i nā holoholona i mea e hoʻolaha ai nā ʻanoʻano. Hoʻohana ʻia nā aʻa a me nā kūpe o ka mea kanu e hana i ka lāʻau.

Hoʻohana ʻia ka māiʻu o Diabolo no ka ʻeha o ke kua, osteoarthritis, rheumatoid arthritis (RA), a me nā kūlana ʻē aʻe, akā ʻaʻohe hōʻike ʻepekema maikaʻi e kākoʻo i kēia mau hoʻohana.

ʻO ka maʻi Coronavirus 2019 (COVID-19): Hoʻomaopopo kekahi mau loea i ke kākā o ka diabolō e hoʻopilikia paha i ka pane o ke kino e kūʻē iā COVID-19. ʻAʻohe ʻikepili ikaika e kākoʻo i kēia ʻōlelo aʻoaʻo. Akā ʻaʻohe hoʻi ʻikepili maikaʻi e kākoʻo i ka hoʻohana ʻana i ka māiʻuʻu diabolo no COVID-19.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no CLAW KAHIKO penei:

E kūpono paha no ...

• ʻEha kua. ʻO ka lawe ʻana i ka māiʻuʻu o ka diabolō e ka waha me he mea lā e hōʻemi ana i ka ʻeha haʻahaʻa. Ke hana nei nā māiʻu o Diabolo e like me kekahi mau lāʻau anti-inflammatory non-steroidal (NSAIDs).
• ʻO Osteoarthritis. Lawe wale i ka māiʻu diabolō, me nā mea hana ʻē aʻe, a i ʻole me nā lāʻau anti-inflammatory nonsteroidal (NSAIDs) me he mea lā e kōkua i ka hōʻemi ʻana i ka ʻeha pili i ka osteoarthritis. Hōʻike kekahi mau hōʻike e hana ana ka māiʻuʻu o ke diabolo e like me diacerhein (kahi lāʻau lohi no ka osteoarthritis i loaʻa ʻole ma ka US) no ka hoʻomaikaʻi ʻana i ka ʻeha osteoarthritis ma ka ʻūhā a me ke kuli ma hope o 16 mau pule o ka lapaʻau. ʻO kekahi poʻe e lawe ana i ka māiʻuʻu diabolō e like me ka hiki ke hoʻohaʻahaʻa i ka mahele lāʻau o nā NSAID e pono ai no ka ʻehaʻeha.

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• Rheumatoid arthritis (RA). Hōʻike ka noiʻi mua i ka lawe ʻana i ka māiʻuʻu diabolō e ka waha ʻaʻole paha e hoʻomaikaʻi iā RA.
• ʻO ka paʻakikī o nā aʻa (atherosclerosis).
• ʻEha ʻeha ʻoi i ka hanu ʻana (ʻeha o ka umauma pleuritic).
• ʻO Fibromyalgia.
• Goute.
• Kolesterol kiʻekiʻe.
• Loaʻa ka ʻai ʻole.
• ʻEha ʻeha.
• ʻO Migraine.
• Hoʻopilikia (dyspepsia).
• Fiva.
• Hoʻopiʻi Menstrual (dysmenorrhea).
• Nā wā kū ʻole.
• Nā paʻakikī i ka wā hānau.
• Pehu (pehu) o kahi tendon (tendinitis).
• Nā Pāhoihoi.
• ʻO ka maʻi hōʻino a me ka maʻi ʻaʻai.
• Hoʻōla hōʻeha, ke kau ʻia i ka ʻili.
• Nā kūlana ʻē aʻe.

Pono nā hōʻike hou aʻe e helu i ka māiʻuʻu diabolō no kēia mau hoʻohana.

Aia i ka māiʻuʻu ʻo Diabolo nā kemika e hōʻemi ai i ka lū a me ka pehu ʻana a me ka hopena o ka ʻeha.

Ke lawe ʻia e ka waha: Nao ka diabolo SAFE MAU PONO no ka hapanui o nā mākua ke lawe ʻia no hoʻokahi makahiki. ʻO ka hopena maʻa mau ka diarrhea. Hiki i nā hopena ʻē aʻe ke komo i ka nausea, ka luaʻi, ka ʻōpū o ka ʻōpū, ke poʻo o ke poʻo, ke kani ʻana i nā pepeiao, ka nele o ka makemake, a me ka nalo o ka ʻono. Hoʻokumu pū ʻia ka maiu o Diabolo i nā hopena o ka ʻili āpau, nā pilikia menstrual, a me nā loli i ke kaomi koko ʻAno ʻole kēia mau hanana.

ʻAʻole lawa ka ʻike hilinaʻi e ʻike ai inā palekana ka māiʻuʻi o ka diabolō ke lawe ʻia no ka lōʻihi o hoʻokahi makahiki.

Ke hoʻopili ʻia i ka ʻili: ʻAʻole lawa ka ʻike hilinaʻi e ʻike ai inā palekana ka māiʻuʻu diabolō a he aha nā hopena ʻē aʻe.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hapai keiki: Nao ka diabolo POSSIBLY UNSAFE ke hoʻohana ʻia i ka wā hāpai. Hoʻopilikia paha ia i ka fetus ke ulu nei. Pale hoʻohana.

Hānai umauma: ʻAʻole lawa ka ʻike hilinaʻi e ʻike ai inā palekana ka māiʻuʻi o ka diabolō i ka wā e hānai ana i ka umauma. Noho ma ka ʻaoʻao palekana a pale i ka hoʻohana.

Nā pilikia puʻuwai, ke koko kiʻekiʻe, kahe haʻahaʻa: Hoʻopili paha ka māiʻu o Diabolo i ka helu o ka puʻuwai, ka puʻuwai, a me ke kahe o ke koko. Hoʻopilikia paha ia i ka poʻe me nā maʻi o ka puʻuwai a me ka ʻōnaehana puni. Inā loaʻa iā ʻoe kekahi o kēia mau kūlana, e kamaʻilio me kāu kauka olakino ma mua o ka hoʻomaka ʻana i ka māiʻuʻu diabolō.

Diabetes: ʻO ka maiuu o Diabolo e hoʻohaʻahaʻa ai i nā pae kō kō.Ke hoʻohana nei ia me nā lāʻau e hoʻohaʻahaʻa i ke kō i ke kō e hoʻoliʻiliʻi haʻahaʻa i ke kō kō. Nānā pono i nā pae glucose koko. Pono paha kāu kauka e hoʻoponopono i kāu mahele o nā lāʻau diabetes.

Nā Pohaku: Hoʻonui ka māiʻuʻu ʻo Devil i ka hana bile. He pilikia paha kēia no nā poʻe me nā pōhaku ʻeho. Hōʻalo i ka hoʻohana ʻana i ka māiʻuʻu diabolō.

Nā pae haʻahaʻa o ka sodium i loko o ke kino: E hōʻemi paha ka māiʻu diabolō i nā pae o ka sodium i loko o ke kino. Hoʻonui paha kēia i nā ʻōuli i ka poʻe i loaʻa nā pae haʻahaʻa o ka sodium.

Peptic ulcer maʻi (PUD): Ma muli o ka hoʻonui ʻana o ka māiʻu diabolō i ka hana ʻana o nā ʻōpū o ka ʻōpū hiki i kēia mea ke hōʻeha i ka poʻe me ka maʻi kōpū. Hōʻalo i ka hoʻohana ʻana i ka māiʻuʻu diabolō

Kānāwai

E akahele me kēia hui ʻana.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 2C19 (CYP2C19) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hōʻemi paha ka maiuu o Diabolo i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. Lawe i ka māiʻu diabolō me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa hiki ke hoʻonui i nā hopena a me nā hopena o kekahi mau lāʻau. Ma mua o ka kamaʻilio ʻana o ka māiʻuʻi diabolō me kāu kauka inā e lawe ʻoe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa pū kekahi me ka omeprazole (Prilosec), lansoprazole (Prevacid), a me ka pantoprazole (Protonix); diazepam (Valium); carisoprodol (Soma); nelfinavir (Viracept); a me kekahi poʻe ʻē aʻe.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 2C9 (CYP2C9) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hōʻemi paha ka māiʻuʻu Diabolo i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. Lawe i ka māiʻu diabolō me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa hiki ke hoʻonui i nā hopena a me nā hopena o kekahi mau lāʻau. Ma mua o ka kamaʻilio ʻana o ka māiʻuʻi diabolō me kāu kauka inā e lawe ʻoe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa me diclofenac (Cataflam, Voltaren), ibuprofen (Motrin), meloxicam (Mobic), a me piroxicam (Feldene); celecoxib (Celebrex); amitriptyline (Elavil); warfarin (Coumadin); glipizide (Glucotrol); losartan (Cozaar); a me kekahi poʻe ʻē aʻe.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 3A4 (CYP3A4) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hōʻemi paha ka māiʻuʻu Diabolo i ka wikiwiki o ka haki o ke ake i kekahi mau lāʻau. Lawe i ka māiʻu diabolō me kekahi mau lāʻau i wāwahi ʻia e ke akepaʻa hiki ke hoʻonui i nā hopena a me nā hopena o kekahi mau lāʻau. Ma mua o ka lawe ʻana i ka māiʻuʻu diabolō, e kamaʻilio me kāu kauka inā ʻoe e lawe i nā lāʻau i hoʻololi ʻia e ke ake.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa me ka lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), a me nā mea ʻē aʻe he nui.

Warfarin (Coumadin)

Hoʻohana ʻia ʻo Warfarin (Coumadin) e hoʻolohi i ke kāpili ʻana o ke koko. Hoʻonui paha ka māiʻuʻu ʻo Diabolo i nā hopena o warfarin (Coumadin) a hoʻonui i nā manawa o ka palapū a me ke kahe ʻana o ke kahe. E nānā pono e nānā pinepine i kou koko. Pono e hoʻololi i ka hopena o kāu warfarin (Coumadin).

Mea liʻiliʻi

E makaʻala me kēia hui pū.

Neʻe ʻia nā lāʻau e nā pauma i nā hunaola (P-glycoprotein Substrates)

Hoʻoneʻe ʻia kekahi mau lāʻau e nā pauma i nā hunaola. Hiki i ka māiʻuʻu ʻo Diabolo ke hana i kēia mau pauma i ka liʻiliʻi o ka hana a hoʻonui i ka nui o kekahi o nā lāʻau i komo i ke kino. Hoʻonui paha kēia i nā hopena ʻaoʻao o kekahi mau lāʻau.

ʻO kekahi mau lāʻau e hoʻoneʻe ʻia e kēia mau pumps e komo pū ana me ka etoposide, paclitaxel, vinblastine, vincristine, vindesine, ketoconazole, itraconazole, amprenavir, indinavir, nelfinavir, saquinavir, cimetidine, ranitidine, diltiazem, verapamil, cortidosteride Allegra), cyclosporine, loperamide (Imodium), quinidine, a me nā mea ʻē aʻe.

Nā lāʻau e hoʻemi ai i ka acid acid (H2-blockers)

Hoʻonui ka māiʻuʻu Diabolo i ka waikawa ʻōpū. Ma ka hoʻonui ʻana i ka waikawa ʻōpū, hoʻoliʻiliʻi ka maiu o ka diabolō i ka pono o kekahi mau lāʻau e hōʻemi i ka waikawa o ka ʻōpū, i kapa ʻia ʻo H2-blockers.

ʻO kekahi mau lāʻau e hoʻemi i ka waikawa ʻōpū me cimetidine (Tagamet), ranitidine (Zantac), nizatidine (Axid), a me famotidine (Pepcid).

Nā lāʻau e hoʻemi ai i ka acid acid (proton pump inhibitors)

Hoʻonui ka māiʻuʻu Diabolo i ka acid acid. Ma ka hoʻonui ʻana i ka waikawa ʻōpū, hoʻoliʻiliʻi ka maiu o ka diabolō i ka pono o nā lāʻau i hoʻohana ʻia e hoʻoliʻiliʻi i ka waikawa ʻōpū, i kapa ʻia nā mea kūpale proton pump.

ʻO kekahi mau lāʻau e hoʻemi i ka waikawa ʻōpū me omeprazole (Prilosec), lansoprazole (Prevacid), rabeprazole (Aciphex), pantoprazole (Protonix), a me esomeprazole (Nexium).

ʻAʻole ʻike ʻia nā launa pū me nā mea kanu a me nā mea hoʻopili.

ʻAʻole ʻike ʻia nā launa me nā meaʻai.

Ua aʻo ʻia nā mahele aʻe i ka noiʻi ʻepekema:

E ka waha:

• No ka osteoarthritis: Ua lawe ʻia ʻo 2-2.6 gram o ka māiʻuʻu o ka māiʻuʻu o ke diabolo i ʻekolu mau mahele i hoʻokaʻawale ʻia i kēlā me kēia lā a hiki i ka 4 mau mahina. ʻO kahi huahana hoʻohui kikoʻī e hāʻawi ana i ka 600 mg o ka māiʻuʻu diabolō, 400 mg o ka turmeric, a me 300 mg o bromelain i lawe ʻia 2-3 ʻekolu mau manawa i kēlā me kēia lā a hiki i 2 mau mahina. ʻO kahi huahana hoʻohui kikoʻī (Rosaxan, medAgil Gesundheitsgeschch mbH) i piha i ka māiʻuʻu diabolō, ʻupena ʻawa, rose hip, a me ka wikamina D i lawe ʻia e ka waha e like me 40 mL i kēlā me kēia lā i hoʻohana ʻia no 12 mau pule.
• No kaʻeha hope: Ua lawe ʻia ʻo 0.6-2.4 gram o ka māiʻuʻu o ka māiʻuʻu i kēlā me kēia lā, ma ka maʻa mau i nā mahele i hoʻokaʻawale ʻia, a hiki i ka 1 makahiki.

ʻO Devils Claw, Devil's Claw Root, Garra del Diablo, Grapple Plant, Griffe du Diable, Harpagophyti Radix, Harpagophytum, Harpagophytum procumbens, Harpagophytum zeyheri, Racine de Griffe du Diable, Racine de Windhoek, Teufelskrallenwurzens, Uncar.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. ʻO Carvalho RR, Donadel CD, Cortez AF, Valviesse VR, Vianna PF, Correa BB. ʻO J Bras Nefrol. 2017 Mar; 39: 79-81. Nānā kiʻi ʻole.
2. ʻOi aku ʻo M, Gruenwald J, Pohl U, Uebelhack R. A Rosa canina - Urtica dioica - Harpagophytum procumbens / zeyheri hui pū me ka hōʻemi nui ʻana i nā hōʻailona gonarthritis i loko o kahi noiʻi, makapo makapo makapo ʻelua. ʻO Planta Med. 2017 Dec; 83: 1384-91. Nānā kiʻi ʻole.
3. Mahomed IM, Ojewole JAO. ʻO ka hopena like Oxytocin o Harpagophytum procumbens [Pedaliacae] kekona aqueous iʻa iʻa ma ka ʻohana i hoʻokaʻawale ʻia iole. ʻO Afr J Trad CAM 2006; 3: 82-89.
4. Cuspidi C, Sala C, Tadic M, et al. ʻO ka hypertension ʻōnaehana i hoʻokomo ʻia e Harpagophytum procumbens (claw a ka diabolō): kahi hōʻike hihia. ʻO J Clin Hypertens (Greenwich) 2015; 17: 908-10. Nānā kiʻi ʻole.
5. ʻO Conrozier T, Mathieu P, Bonjean M, et al. ʻO kahi paʻakikī o ʻekolu mau mea anti-inflammatory kūlohelohe e hāʻawi i ke kōkua o ka ʻeha osteoarthritis. ʻO Med Ther Health Med. 2014; 20 Hōʻawi 1: 32-7.
6. Chrubasik S, Sporer F, a me Wink M. [Harpagoside maʻiʻo o nā ʻāpana lepo maloʻo like ʻole mai Harpagophytum procumbens]. Forsch Komplmentarmed 1996; 3: 6-11.
7. Chrubasik S, Schmidt A, Junck H, a me et al. [Ka hopena a me ka hoʻokele waiwai o Harpagophytum huki i ka mālama ʻana i ka ʻehaʻeha o ke kua i hope loa - nā hopena mua o kahi noiʻi cohort therapeutic]. Forsch Komplementarmed 1997; 4: 332-336.
8. Chrubasik S, Model A, Black A, a me nā mea ʻē aʻe. ʻO kahi noiʻi pilote makapō makapō makapō e hoʻohālikelike ana iā Doloteffin® a me Vioxx® i ka mālama ʻana i ka ʻehaʻeha haʻahaʻa. Rheumatology 2003; 42: 141-148.
9. ʻO Biller, A. Ergebnisse sweier randomisieter kontrollierter. Phyto-pharmaka 2002; 7: 86-88.
10. Schendel, U. Hoʻomaʻamaʻa ʻana i ka artritis: Study with Devil Claw extract [i ka ʻōlelo Kelemania]. Der Kassenarzt 2001; 29/30: 2-5.
11. Usbeck, C. Teufelskralle: Moko o ka diabolō: Hoʻomaʻo no ka ʻeha mau loa [ma Kelemania]. Arzneimittel-Forum 2000; 3: 23-25.
12. Rutten, S. and Schafer, I. Einsatz der afrikanischen Teufelskralle [Allya] bei Erkrankungen des Stutz unde Bewegungsapparates. Ergebnisse einer Anwendungscbeobachtung Acta Biol 2000; 2: 5-20.
13. Pinget, M. a me Lecomte, A. Ka hopena o Harpagophytum Arkocaps i ka degenerative rheumatism [i ka ʻōlelo Kelemania]. Naturheilpraxis 1997; 50: 267-269.
14. ʻO Ribbat JM a me Schakau D. Behandluing Chronisch aktivierter Schmerzen am Bewegungsapparat. NaturaMed 2001; 16: 23-30.
15. Loew D, Schuster O, a me Möllerfeld J. Stabilität und biopharmazeutische Qualität. ʻO Voraussetzung für ʻO Bioverfügbarkeit von Harpagophytum procumbens. I: Loew D a me Rietbrock N. Phytopharmaka II. Forschung und klinische Anwendung. Darmstadt: Forschung und klinische Anwendung; 1996.
16. ʻO Tunmann P lāua ʻo Bauersfeld HJ. Über weitere Inhaltsstoffe der Wurzel von Harpagophytum procumbens DC. ʻO Arch Pharm (Weinheim) 1975; 308: 655-657.
17. ʻO Ficarra P, ʻo Ficarra R, ʻo Tommasini A, a me et al. [Ka nānā ʻana ʻo HPLC i kahi lāʻau i ka lāʻau kuʻuna: Harpagophytum procumbens DC. I]. ʻO Boll Chim Farm 1986; 125: 250-253.
18. ʻO Tunmann P lāua ʻo Lux R. Zur Kenntnis der Inhaltsstoffe aus der Wurzel von Harpagophytum procumbens DC. DAZ 1962; 102: 1274-1275.
19. ʻO Kikuchi T. Nā glucosides iridoid hou mai Harpagophytum i hoʻolaha. ʻO Chem Pharm Bull 1983; 31: 2296-2301.
20. ʻO Zimmermann W. Pflanzliche Bitterstoffe ma ka Gastroenterologie. Z Allgemeinmed 1976; 23: 1178-1184.
21. Van Haelen M, van Haelen-Fastré R, Samaey-Fontaine J, a me et al. Nā ʻano botaniques, kumukānāwai chimique a me activité pharmacologique d'Harpagophytum procumbens. Phytotherapy 1983; 5: 7-13.
22. Chrubasik S, Zimpfer C, Schutt U, a me et al. Ka hopena o Harpagophytum e hoʻolaha i ka mālama ʻana i ka ʻehaʻeha o ke kua i hope. Phytomedicine 1996; 3: 1-10.
23. Chrubasik S, Sporer F, Wink M, a me et al. Zum wirkstoffgehalt in arzneimitteln aus harpagophytum procumbens. Forsch Komplementärmed 1996; 3: 57-63.
24. Chrubasik S, Sporer F, a me Wink M. [ʻImi o nā mea hana i nā hoʻomākaukau kī mai Harpagophytum procumbens]. ʻO Forsch Komplementarmed 1996; 3: 116-119.
25. Langmead L, Dawson C, Hawkins C, a me et al. Nā hopena Antioxidant o nā lāʻau lapaʻau i hoʻohana ʻia e nā mea maʻi me ka maʻi ʻōpala: he noi in vitro. Aliment Pharmacol Ther 2002; 16: 197-205.
26. ʻO Bhattacharya A a me Bhattacharya SK. ʻO ka hana anti-oxidative o Harpagophytum procumbens. ʻO Br J Phytother 1998; 72: 68-71.
27. ʻO Schmelz H, Haemmerle HD, a ʻo Springorum HW. Analgetische Wirksamkeit eines Teufels-krallenwurzel-Extraktes bei verschiedenen kronisch-degenerativen Gelenkerkrankungen. I: Chrubasik S a me Wink M. Rheumatherapie mit Phytopharmaka. ʻO Stuttgart: Hippokrates; 1997.
28. ʻO Frerick H, Biller A, a me Schmidt U. Stufenschema bei Coxarthrose. Der Kassenarzt 2001; 5:41.
29. Schrüffer H. Salus Teufelskralle-Tabletten. Ein Fortschritt in der nichtsteroidalen antirheumatischen Therapie. Die Medizinische Publikation 1980; 1: 1-8.
30. ʻO Pinget M lāua ʻo Lecompte A. Etude des effets de I'harpagophytum en rhumatologie dégénérative. 37 Le makasina 1990;: 1-10.
31. ʻO Lecomte A a me Costa JP. Harpagophytum dans lʻarthrose: Etude en pālua insu contre placebo. Le Magazine 1992; 15: 27-30.
32. ʻO Guyader M. Les kanu i nā antirhumatismales. Etude historique et pharmacologique, et etude clinique du nebulisat d'Harpagohytum procumbens DC chez 50 nā mea maʻi arthrosiques suivis en service hospitalitalier [Dissertation]. Kulanui ʻo Pierre et Marie Curie, 1984.
33. Belaiche P. Etude clinique de 630 cas dʻartrose traites par le nebulisat aqueux d'Harpagophytum procumbens (Radix). Phytotherapy 1982; 1: 22-28.
34. Chrubasik S, Fiebich B, ʻEleʻele A, a me et al. ʻO ka mālama ʻana i ka ʻehaʻeha o ke kua me kahi unuhi o Harpagophytum procumbens e pāpā i ka hoʻokuʻu ʻana o cytokine. Eur J Anaesthesiol 2002; 19: 209.
35. ʻO Chrubasik S a me Eisenberg E. Hoʻomaʻamaʻa i ka ʻeha rheumatic me Kampo lāʻau i ʻEulopa. ʻO Pain Clinic 1999; 11: 171.
36. ʻO Jadot G lāua ʻo Lecomte A. Activite anti-inflammatoire d'Harpagophytum procumbens DC. Lyon Mediteranee Med Sud-Est 1992; 28: 833-835.
37. Fontaine, J., Elchami, A. A., Vanhaelen, M., a me Vanhaelen-Fastre, R. [Nānā biological o Harpagophytum procumbens D.C. II. ʻO ka loiloi Pharmacological o nā hopena o harpagoside, harpagide a me harpagogenine ma kahi kaʻawale o ka guinea-pig ileum (transl a ka mea kākau)]. ʻO J Pharm Belg. 1981; 36: 321-324. Nānā kiʻi ʻole.
38. ʻO Eichler, O. a me Koch, C. [Antiphlogistic, analgesic a me ka hopena spasmolytic o harpagoside, kahi glycoside mai ke aʻa o Harpagophytum procumbens DC]. Arzneimittelforschung. 1970; 20: 107-109. Nānā kiʻi ʻole.
39. ʻO Occhiuto, F., Circosta, C., Ragusa, S., Ficarra, P., a me Costa, De Pasquale. ʻO kahi lāʻau i hoʻohana ʻia i ka lāʻau kuʻuna: Harpagophytum procumbens DC. IV. Nā hopena i kekahi o nā hoʻomākaukau mākala kaʻawale. ʻO J Ethnopharmacol. 1985; 13: 201-208. Nānā kiʻi ʻole.
40. ʻO Erdos, A., Fontaine, R., Friehe, H., Durand, R., a me Poppinghaus, T. [Ka hāʻawi ʻana i ka lāʻau lāʻau a me nā lāʻau ʻona o nā extract like ʻole a me ka harpagosid mai Harpagophytum procumbens DC]. Planta Med 1978; 34: 97-108. Nānā kiʻi ʻole.
41. ʻO Brien, S., Lewith, G. T., a me McGregor, ʻo G. Devil's Claw (Harpagophytum procumbens) ma ke ʻano he lapaʻau no ka osteoarthritis: he loiloi i ka pono a me ka palekana. J Altern Complement Med 2006; 12: 981-993. Nānā kiʻi ʻole.
42. Grant, L., McBean, D. E., Fyfe, L., a me Warnock, A. M. He loiloi i nā hana olaola a me nā hopena kūpono o Harpagophytum procumbens. Phytother Res 2007; 21: 199-209. Nānā kiʻi ʻole.
43. ʻO Ameye, L. G. a me Chee, W. S. Osteoarthritis a me ka meaʻai. Mai nā lāʻau lapaʻau i nā meaʻai kūpono: kahi ʻōnaehana loiloi o nā ʻike ʻepekema. ʻO Arthritis Res Ther 2006; 8: R127. Nānā kiʻi ʻole.
44. ʻO Teut, M. a me Warning, A. [Iwi metastases i ka umauma carcinoma]. Forsch Komplement. Ma 2006, 13: 46-48. Nānā kiʻi ʻole.
45. Kundu, J. K., Mossanda, K. S., Na, H. K., a me Surh, Y. J. Nā hopena o ka hopena o Sutherlandia frutescens (L.) R. Br. a hoʻolaha ʻo Harpagophytum iā DC. ma ka phorbol ester-i hoʻokomo ʻia COX-2 ʻōlelo i ka ʻiole ʻiole: AP-1 a me CREB ma ke ʻano he pahu hopu i hiki. Kāpena Lett. 1-31-2005; 218: 21-31. Nānā kiʻi ʻole.
46. Chrubasik, S. Hoʻohui i ka monograp ESCOP ma Harpagophytum procumbens. Phytomedicine. 2004; 11 (7-8): 691-695. Nānā kiʻi ʻole.
47. Kaszkin, M., Beck, KF, Koch, E., Erdelmeier, C., Kusch, S., Pfeilschifter, J., a me Loew, D. Downregulation o iNOS ʻōlelo i loko o nā ʻiole mesangial iole e nā ʻāpana kūikawā o Harpagophytum procumbens i loaʻa mai nā hopena kūlike i ka harpagoside a me ke kūʻokoʻa. Phytomedicine. 2004; 11 (7-8): 585-595. Nānā kiʻi ʻole.
48. Na, H. K., Mossanda, K. S., Lee, J. Y., a me Surh, Y. J. Kaohi ʻana i ka ʻōlelo COX-2 i hoʻokomo ʻia e ka ester phorbol e kekahi mau mea kanu ʻApelika ʻai. Nā Biofactors 2004; 21 (1-4): 149-153. Nānā kiʻi ʻole.
49. Chrubasik, S. [Koʻi o ka māiʻuʻu Diabolō ma ke ʻano he laʻana o ka pono o nā lāʻau analgesics]. Orthopade 2004; 33: 804-808. Nānā kiʻi ʻole.
50. Schulze-Tanzil, G., Hansen, C., a me Shakibaei, M. [Ka hopena o kahi Harpagophytum e lawe ai i ka DC extract ma ka matrix metalloproteinases i loko o nā chondrocytes kanaka i vitro]. Arzneimittelforschung. 2004; 54: 213-220. Nānā kiʻi ʻole.
51. Chrubasik, S., Conradt, C., a me Roufogalis, B. D. Ka hopena o nā Harpagophytum extracts a me ka pono o ka haukapila. ʻO Phytother.Res. 2004; 18: 187-189. Nānā kiʻi ʻole.
52. Boje, K., Lechtenberg, M., a me Nahrstedt, A. Hou a kaulana iridoid- a me phenylethanoid glycosides mai Harpagophytum procumbens a me kā lākou in vitro kaohi o ka leukositte elastase kanaka. Planta Med 2003; 69: 820-825. Nānā kiʻi ʻole.
53. ʻO Clarkson, C., Campbell, W. E., a me Smith, P. In vitro antiplasmodial hana o abietane a me totarane diterpenes i hoʻokaʻawale ʻia mai Harpagophytum procumbens (kuʻi o ka diabolō). Planta Med 2003; 69: 720-724. Nānā kiʻi ʻole.
54. ʻO Betancor-Fernandez, A., Perez-Galvez, A., Sies, H., a me Stahl, W. Ke hoʻomākaukau ʻana i ka lāʻau no ka hoʻomake ʻana i ka rhizome turmeric, ka lau artichoke, ke aʻa aʻa a ka diabolo a me ka aila a i ʻole aila salemona no ka hiki i ka antioxidant. ʻO J Pharm Pharmacol 2003; 55: 981-986. Nānā kiʻi ʻole.
55. Munkombwe, N. M. Acetylated phenolic glycosides mai Harpagophytum procumbens. Phytochemistry 2003; 62: 1231-1234. Nānā kiʻi ʻole.
56. Gobel, H., Heinze, A., Ingwersen, M., Niederberger, U., a me Gerber, D. [Nā hopena o Harpagophytum procumbens LI 174 (claw o ka diabolō) ma ka sensory, reagibility muscle mus vaskular reagibility i ka mālama ʻana i ke kua kūpono ʻole ʻeha]. ʻO Schmerz. 2001; 15: 10-18. Nānā kiʻi ʻole.
57. Laudahn, D. a me Walper, A. Efficacy a me ke ahonui o Harpagophytum e lawe i ka LI 174 i nā mea maʻi me ka ʻehaʻeha non-radicular hoʻi. ʻO Phytother.Res. 2001; 15: 621-624. Nānā kiʻi ʻole.
58. Loew, D., Mollerfeld, J., Schrodter, A., Puttkammer, S., a me Kaszkin, M. Ninaninau e pili ana i nā pono lāʻau o ka Harpagophytum extracts a me nā hopena e pili ana i ka biosynthesis eicosanoid in vitro and ex vivo. ʻO Clin.Pharmacol.Ther. 2001; 69: 356-364. Nānā kiʻi ʻole.
59. ʻO Leblan, D., Chantre, P., a me Fournie, B. Harpagophytum e hoʻolaha i ka mālama ʻana i ke kuli a me ka hip osteoarthritis. Nā hopena ʻehā mau mahina o kahi hoʻokolohua prospective, multicenter, pālua makapō me diacerhein. Iwi Iwi Spine 2000; 67: 462-467. Nānā kiʻi ʻole.
60. Baghdikian, B., Guiraud-Dauriac, H., Ollivier, E., N'Guyen, A., Dumenil, G., a me Balansard, G. Ke hoʻokumu ʻia ʻana o nā metabolite i loaʻa ʻia me nitrogen mai nā iridoids nui o Harpagophytum procumbens a me H. zeyheri e nā koʻohune ʻōpū kanaka. Planta Med 1999; 65: 164-166. Nānā kiʻi ʻole.
61. Chrubasik, S., Junck, H., Breitschwerdt, H., Conradt, C., a me Zappe, H. Ka hopena o Harpagophytum extract WS 1531 i ka hoʻomaʻamaʻa ʻana i ka ʻeha o ke kua haʻahaʻa: kahi i hoʻokau ʻia, placebo-kāohi ʻia, pālua hoʻopaʻa makapō. Eur.J Anaesthesiol. 1999; 16: 118-129. Nānā kiʻi ʻole.
62. ʻO Gagnier, J. J., van Tulder, M., Berman, B., a me Bombardier, C. Nā lāʻau lapaʻau no ka ʻehaʻeha haʻahaʻa. ʻO Cochrane.Database.Syst.Rev. 2006;: CD004504. Nānā kiʻi ʻole.
63. Spelman, K., Burns, J., Nichols, D., Winters, N., Ottersberg, S., a me Tenborg, M. Hoʻohālikelike i ka ʻōlelo cytokine e nā lāʻau kūpuna: kahi loiloi o nā immunomodulator lāʻau. Altern.Med.Rev. 2006; 11: 128-150. Nānā kiʻi ʻole.
64. Ernst, E. a me Chrubasik, S. Phyto-anti-inflammatories. ʻO kahi loiloi ʻōnaehana o nā hoʻokolohua kaulike, placebo-kāohi ʻia, pālua makapō. Rheum. Disis Clin North Am 2000; 26: 13-27, vii. Nānā kiʻi ʻole.
65. Romiti N, Tramonti G, Corti A, Chieli E. Nā hopena o ka Devil's Claw (Harpagophytum procumbens) ma ka mea lawe multidrug ABCB1 / P-glycoprotein. Phytomedicine 2009; 16: 1095-100. Nānā kiʻi ʻole.
66. ʻO Gagnier JJ, van Tulder MW, Berman B, Bombardier C. Nā lāʻau lapaʻau no ka ʻehaʻeha haʻahaʻa. He loiloi Cochrane. Spine 2007; 32: 82-92. Nānā kiʻi ʻole.
67. Chrubasik S, Kunzel O, Thanner J, et al. He 1 makahiki ka ukali ma hope o ka hoʻopaʻa pailaka ʻana me Doloteffin no ka ʻehaʻeha haʻahaʻa. Phytomedicine 2005; 12: 1-9. Nānā kiʻi ʻole.
68. ʻO Wegener T, Lupke NP. ʻO ka mālama ʻana i nā mea maʻi me ka arthrosis o ka uha a i ʻole ke kuli me kahi wai aqueous o ka maiu o ka diabolō (Harpagophytum procumbens DC). Phytother Res 2003; 17: 1165-72. Nānā kiʻi ʻole.
69. Unger M, Frank A.ʻO ka hoʻoholo like ʻana o ka ikaika kaohi o nā mea kanu lāʻau i ka hana o ʻeono nui cytochrome P450 enzyme e hoʻohana ana i ka chromatography wai / spectrometry lehulehu a me ka unuhi lima pūnaewele. Rapid Commun Mass Spectrom 2004; 18: 2273-81. Nānā kiʻi ʻole.
70. Jang MH, Lim S, Han SM, et al. Hoʻopili ka Harpagophytum procumbens i ka lipopolysaccharide-stimulate expression o cyclooxygenase-2 a me ka inducible nitric oxide synthase i ka laina fibroblast cell L929. ʻO J Pharmacol Sci 2003; 93: 367-71. Nānā kiʻi ʻole.
71. ʻO Gagnier JJ, Chrubasik S, Manheimer E. Harpgophytum procumbens no ka osteoarthritis a me ka ʻeha haʻahaʻa: he loiloi ʻōnaehana. Hoʻohui BMC Hoʻolaha Med 2004; 4: 13. Nānā kiʻi ʻole.
72. Moussard C, Alber D, Toubin MM, et al. ʻO kahi lāʻau i hoʻohana ʻia i ka lāʻau lapaʻau kuʻuna, harpagophytum procumbens: ʻaʻohe hōʻike no ka hopena e like me NSAID i ka hana ʻana o ke koko eicosanoid āpau i ke kanaka. ʻO Prostaglandins Leukot Essent Fatty Acids. 1992; 46: 283-6 .. Nānā i ka abstract.
73. Whitehouse LW, Znamirowska M, Paul CJ. Devil's Claw (Harpagophytum procumbens): ʻaʻohe hōʻike no ka hana anti-inflammatory i ka mālama ʻana i ka maʻi arthritic. Hiki iā Med Assoc J 1983; 129: 249-51. Nānā kiʻi ʻole.
74. Fiebich BL, Heinrich M, Hiller KO, Kammerer N. Kaohi ʻana o ka synthes TNF-alpha i ka LPS-stimulated mua kanaka monocytes na Harpagophytum extract SteiHap 69. Phytomedicine 2001; 8: 28-30 .. Nānā i nā mea ʻole.
75. Baghdikian B, Lanhers MC, Fleurentin J, et al. ʻO kahi noiʻi anamanaʻo, anti-inflammatory a me nā hopena analgesic o Harpagophytum procumbens a me Harpagophytum zeyheri. Planta Med 1997; 63: 171-6. Nānā kiʻi ʻole.
76. Lanhers MC, Fleurentin J, Mortier F, et al. Nā hopena anti-inflammatory a me analgesic o kahi wai i lawe mai o Harpagophytum procumbens. Planta Med 1992; 58: 117-23. Nānā kiʻi ʻole.
77. Grahame R, Robinson BV. Nā māiʻuʻu o nā diabolō (Harpagophytum procumbens): nā lāʻau lapaʻau a me nā noiʻi maʻi. Ann Rheum Dis 1981; 40: 632. Nānā kiʻi ʻole.
78. Chrubasik S, Sporer F, Dillmann-Marschner R, et al. Nā waiwai Physicochemical o harpagoside a me kāna hoʻokuʻu in vitro mai Harpagophytum procumbens e lawe i nā papa. Phytomedicine 2000; 6: 469-73. Nānā kiʻi ʻole.
79. Soulimani R, Younos C, Mortier F, Derrieu C. Ke kuleana o ka digestion o ka ʻōpū ma ka hana pharmacological o nā mea kanu i nā mea kanu, e hoʻohana ana ma ke ʻano he extracts o Harpagophytum procumbens. Hiki iā J Physiol Pharmacol 1994; 72: 1532-6. Nānā kiʻi ʻole.
80. Costa De Pasquale R, Busa G, et al. ʻO kahi lāʻau i hoʻohana ʻia i ka lāʻau kuʻuna: Harpagophytum procumbens DC. III. Nā hopena ma ka hyperkinetic ventricular arrhythmias e ka reperfusion. ʻO J Ethnopharmacol 1985; 13: 193-9. Nānā kiʻi ʻole.
81. Circosta C, Occhiuto F, Ragusa S, et al. ʻO kahi lāʻau i hoʻohana ʻia i ka lāʻau kuʻuna: Harpagophytum procumbens DC. II. ʻO ka hana Cardiovascular. ʻO J Ethnopharmacol 1984; 11: 259-74. Nānā kiʻi ʻole.
82. Chrubasik S, Thanner J, Kunzel O, et al. Hoʻohālikelike o nā ana hopena i ka wā o ka mālama ʻana me ka Harpagophytum ponoʻī e lawe i ka doloteffin i nā mea maʻi me ka ʻeha ma ka ʻaoʻao haʻahaʻa, ke kuli a me ka ʻūhā. Phytomedicine 2002; 9: 181-94. Nānā kiʻi ʻole.
83. ʻO Barak AJ, Beckenhauer HC, Tuma DJ. Betaine, ethanol, a me ke akepaʻa: he loiloi. ʻAlekohola 1996; 13: 395-8. Nānā kiʻi ʻole.
84. Chantre P, Cappelaere A, Leblan D, et al. Ka hoʻokō ʻana a me ke ahonui a i ʻole Harpagophytum procumbens versus diacerhein i ka mālama ʻana i ka osteoarthritis. Phytomedicine 2000; 7: 177-83. Nānā kiʻi ʻole.
85. ʻO Fetrow CW, ʻo Avila JR. ʻO ka puke lima ʻoihana ʻoihana o nā lāʻau laulima a me nā lāʻau lapaʻau ʻē aʻe. 1st ed. ʻO Springhouse, PA: Springhouse Corp., 1999.
86. Krieger D, Krieger S, Jansen O, et al. ʻO ka manganese a me ka encephalopathy hepatic mau. Lancet 1995; 346: 270-4. Nānā kiʻi ʻole.
87. Shaw D, Leon C, Kolev S, Murray V. Nā lāʻau kūpuna a me nā mea hoʻopihapiha meaʻai: kahi 5 makahiki i hoʻopaʻa ʻia (1991-1995). Lāʻau lapaʻau Saf 1997; 17: 342-56. Nānā kiʻi ʻole.
88. ʻO Brinker F. Herb Contraindications a me nā launa lāʻau. ʻElua ed. Sandy, OR: Nā Papa Hana Lapaʻau Eclectic, 1998.
89. ʻO Wichtl MW. Nā lāʻau lapaʻau lāʻau a me nā lāʻau lapaʻau. Ed. NM Bisset. Stuttgart: Medpharm GmbH Scientific Publishers, 1994.
90. Newall CA, Anderson LA, Philpson JD. Laau Lapaʻau: He alakaʻi no nā ʻoihana mālama ola. Ladana, UK: Ka Hale Paʻi Lapaʻau, 1996.

Nānā hope - 05/06/2020